Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coda Signature was a premium cannabis-infused products company that specialized in the development of gourmet edibles, topicals, and concentrates. Founded in 2015 and based in Colorado, the company was widely recognized for its artisanal approach, combining high-quality CO2-extracted cannabinoids with premium ingredients like South American cacao. Their product portfolio included award-winning chocolate bars, truffles, and 'Active' topical salves designed for targeted relief of pain and inflammation. Coda Signature operated within the regulated legal cannabis market, focusing on consistent dosing and sophisticated flavor profiles to appeal to wellness-conscious consumers. Despite its status as a leading brand and multiple industry awards, the company announced it was ceasing operations in late 2023 due to challenging market conditions. At its peak, Coda Signature was considered a pioneer in the luxury cannabis sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coda Signature.